{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:13:16Z","timestamp":1790161996869,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04355-z","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:06:00Z","timestamp":1777097160000},"page":"4749-4757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic landscape and clinicopathological predictors of survival in gallbladder cancer"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-9846","authenticated-orcid":false,"given":"Manoj","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Vijay","family":"Chigurupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"6","key":"4355_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1023\/A:1010652105532","volume":"46","author":"M Pandey","year":"2001","unstructured":"Pandey M, Pathak AK, Gautam A, Aryya NC, Shukla VK. Carcinoma of the gallbladder: a retrospective review of 99 cases. Dig Dis Sci. 2001;46(6):1145\u201351.","journal-title":"Dig Dis Sci"},{"key":"4355_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.12.014","author":"Z Fu","year":"2026","unstructured":"Fu Z, Song Y, Liu F, Chen L, Cai S, Cui P, et al. Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer. Cancer Cell. 2026. https:\/\/doi.org\/10.1016\/j.ccell.2025.12.014.","journal-title":"Cancer Cell"},{"issue":"1","key":"4355_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00008469-200302000-00004","volume":"12","author":"M Pandey","year":"2003","unstructured":"Pandey M. Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev. 2003;12(1):15\u201324.","journal-title":"Eur J Cancer Prev"},{"issue":"7","key":"4355_CR4","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1007\/s11033-022-07448-4","volume":"49","author":"R Dixit","year":"2022","unstructured":"Dixit R, Pandey M, Rajput M, Shukla VK. Unravelling of the comparative transcriptomic profile of gallbladder cancer using mRNA sequencing. Mol Biol Rep. 2022;49(7):6395\u2013403.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"4355_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11033-025-10607-y","volume":"52","author":"R Dixit","year":"2025","unstructured":"Dixit R, Pandey M, Shukla VK. Bioprospecting potential genetic biomarkers of gallbladder cancer. Mol Biol Rep. 2025;52(1):514.","journal-title":"Mol Biol Rep"},{"issue":"24","key":"4355_CR6","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1158\/1078-0432.CCR-22-1954","volume":"28","author":"NA Giraldo","year":"2022","unstructured":"Giraldo NA, Drill E, Satravada BA, Dika IE, Brannon AR, Dermawan J, et al. Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention. Clin Cancer Res. 2022;28(24):5359\u201367.","journal-title":"Clin Cancer Res"},{"key":"4355_CR7","volume":"830","author":"M Kumar","year":"2025","unstructured":"Kumar M, Kumar A, Srivastav A, Ghosh A, Kumar D. Genomic and molecular landscape of gallbladder cancer elucidating pathogenic mechanisms novel therapeutic targets and clinical implications. Mutat Res. 2025;830:111896.","journal-title":"Mutat Res"},{"key":"4355_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf430","author":"S Limaye","year":"2026","unstructured":"Limaye S, Shreenivas A, Patil D, Vyas S, George IA, Sambath J, et al. Actionable genomic landscape of biliary tract cancer in the Indian population. Oncologist. 2026. https:\/\/doi.org\/10.1093\/oncolo\/oyaf430.","journal-title":"Oncologist"},{"issue":"2","key":"4355_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2023.100301","volume":"104","author":"S Mishra","year":"2024","unstructured":"Mishra S, Srivastava P, Pandey A, Shukla S, Agarwal A, Husain N. Diagnostic utility of next-generation sequencing in circulating free DNA and a comparison with matched tissue in gallbladder carcinoma. Lab Invest. 2024;104(2):100301.","journal-title":"Lab Invest"},{"key":"4355_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/GO-25-00332","volume":"11","author":"M Suryavanshi","year":"2025","unstructured":"Suryavanshi M, Ostwal V, Javle MM, Kumar M, Shetty O, Patil D, et al. Genomic profiling of Indian gallbladder carcinoma: mutational insights in a high-incidence population. JCO Glob Oncol. 2025;11:e2500332.","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"4355_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00327-y","volume":"6","author":"TJJ de Bitter","year":"2022","unstructured":"de Bitter TJJ, de Reuver PR, de Savornin Lohman EAJ, Kroeze LI, Vink-B\u00f6rger ME, van Vliet S, et al. Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients. npj Precis Oncol. 2022;6(1):83.","journal-title":"npj Precis Oncol"},{"issue":"11","key":"4355_CR12","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1097\/JS9.0000000000002031","volume":"110","author":"S Awasthi","year":"2024","unstructured":"Awasthi S, Kumar R, Pradhan D, Rawal N, Goel H, Sahu P, et al. Genomic landscape of gallbladder cancer: insights from whole exome sequencing. Int J Surg. 2024;110(11):6883\u201397.","journal-title":"Int J Surg"},{"key":"4355_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104830","volume":"214","author":"D Das","year":"2025","unstructured":"Das D, Singh P, Pal M, Pandey M, Dixit R. Global perspective on the genetic, epigenetic, and transcriptomic basis of gallbladder cancer. Crit Rev Oncol Hematol. 2025;214:104830.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4355_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1658528","volume":"15","author":"JI Erices","year":"2025","unstructured":"Erices JI, Gonz\u00e1lez E, Salgado M, Barahona-Ponce C, Freire M, Sep\u00falveda-Hermosilla G, et al. The mutational landscape and actionable targets of gallbladder cancer: an ancestry-informed and comparative analysis of a Chilean population. Front Oncol. 2025;15:1658528.","journal-title":"Front Oncol"},{"issue":"1","key":"4355_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8(1):69.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"4355_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100824","volume":"38","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Solis Soto LM, Pant S, Vega EA, Vinuela E, Bozorgui B, et al. Population-specific immunogenomic alterations in gallbladder cancer and prognostic significance. Mod Pathol. 2025;38(11):100824.","journal-title":"Mod Pathol"},{"issue":"11","key":"4355_CR17","doi-asserted-by":"publisher","first-page":"10153","DOI":"10.1007\/s11033-022-07874-4","volume":"49","author":"M Rajput","year":"2022","unstructured":"Rajput M, Chigurupati S, Purwar R, Shukla M, Pandey M. MAP kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: results from bioinformatic analysis of next generation sequencing data from a hospital-based cohort (NCT05404347). Mol Biol Rep. 2022;49(11):10153\u201363.","journal-title":"Mol Biol Rep"},{"issue":"11","key":"4355_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100868","volume":"38","author":"Q Jia","year":"2025","unstructured":"Jia Q, Chen Y, Pan Y, Gao S, Wei X, Fan Y, et al. Clinicopathologic and genomic characterization of SMARCA4-deficient carcinoma of the gallbladder. Mod Pathol. 2025;38(11):100868.","journal-title":"Mod Pathol"},{"issue":"7","key":"4355_CR19","first-page":"4990","volume":"14","author":"L Guo","year":"2022","unstructured":"Guo L, Zhou F, Liu H, Kou X, Zhang H, Chen X, et al. Genomic mutation characteristics and prognosis of biliary tract cancer. Am J Transl Res. 2022;14(7):4990\u20135002.","journal-title":"Am J Transl Res"},{"issue":"4","key":"4355_CR20","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.21873\/anticanres.17529","volume":"45","author":"H Jo","year":"2025","unstructured":"Jo H, Park Y, Kim HP, Kyung DS, Kim KS, Kim K, et al. Blood circulating tumor DNA-based genomic profiling and serial analysis in patients with advanced biliary tract cancer. Anticancer Res. 2025;45(4):1447\u201363.","journal-title":"Anticancer Res"},{"issue":"7","key":"4355_CR21","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/jso.28081","volume":"131","author":"DI Tsilimigras","year":"2025","unstructured":"Tsilimigras DI, Stecko H, Moris D, Pawlik TM. Genomic profiling of biliary tract cancers: comprehensive assessment of anatomic and geographic heterogeneity, co-alterations and outcomes. J Surg Oncol. 2025;131(7):1352\u201361.","journal-title":"J Surg Oncol"},{"key":"4355_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaf065","author":"F Terasaki","year":"2025","unstructured":"Terasaki F, Kumagai S, Fukuda A, Tanaka Y, Irie T, Ito S, et al. KRAS mutations disrupt interactions between CD8+ T cells and antigen-presenting cells in the tumor microenvironment of biliary tract cancer. Int Immunol. 2025. https:\/\/doi.org\/10.1093\/intimm\/dxaf065.","journal-title":"Int Immunol"},{"key":"4355_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100910","volume":"42","author":"C Kumar-Sinha","year":"2023","unstructured":"Kumar-Sinha C, Vats P, Tran N, Robinson DR, Gunchick V, Wu YM, et al. Genomics driven precision oncology in advanced biliary tract cancer improves survival. Neoplasia. 2023;42:100910.","journal-title":"Neoplasia"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04355-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04355-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04355-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:41:44Z","timestamp":1790160104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04355-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4355"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04355-z","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and the protocol was approved by the Institutional Ethics Committee of the Institute of Medical Sciences, Banaras Hindu University. Written informed consent was obtained from all individual participants included in the study prior to recruitment. All participants provided informed consent for the publication of de-identified clinical and genomic data.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Gemini (Google) to edit the manuscript to improve the linguistic clarity, structural flow, and formatting of the manuscript. No data or references were generated using AI. The authors also utilized AI to lay out the graphical abstract and Figs.\n                      \n                      and\n                      \n                      , based on text prompts and data provided by the authors using the deep learning module of Gemini. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the scientific accuracy of the data presented and the final interpretations.","order":3,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing","group":{"name":"EthicsHeading","label":"Declarations"}}]}}